CTNM

Contineum Therapeutics, Inc.

$15.10 -0.14 (-0.92%) At close · Jul 2

Market Cap

$644.97M

37,386,377

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Insider Sentiment Score

Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.

Net buyers

-1

Net shares bought

-0.02%

Net buy value

-$109,556

Date	Insider	Role	Type	Shares	Price	Value	After
2026-07-01	Lorrain Daniel S.	Chief Scientific Officer	Convert	4,183	$1.01	$4,225	143,555
2026-07-01	Lorrain Daniel S.	Chief Scientific Officer	Sell	5,852	$15.67	$91,682	137,703
2026-07-01	Lorrain Daniel S.	Chief Scientific Officer	Sell	2,501	$16.24	$40,608	135,202
2026-07-01	Lorrain Daniel S.	Chief Scientific Officer	Convert	4,183	—	—	34,297
2026-06-30	Watkins Tim	CMO & Head of Development	Convert	10,833	$4.50	$48,749	19,794
2026-06-30	Stengone Carmine N.	Director	Convert	7,500	—	—	281,930
2026-06-30	Lorrain Daniel S.	Chief Scientific Officer	Sell	28,826	$16.04	$462,288	139,372
2026-06-30	Stengone Carmine N.	Director	Convert	7,500	$1.01	$7,575	24,717
2026-06-30	Stengone Carmine N.	Director	Convert	2,500	$1.26	$3,150	27,217
2026-06-30	Lorrain Daniel S.	Chief Scientific Officer	Convert	28,826	—	—	38,480
2026-06-30	Stengone Carmine N.	Director	Convert	2,500	—	—	118,417
2026-06-30	Lorrain Daniel S.	Chief Scientific Officer	Convert	28,826	$1.01	$29,114	168,198
2026-06-30	Watkins Tim	CMO & Head of Development	Convert	10,833	—	—	238,334
2026-06-30	Stengone Carmine N.	Director	Sell	10,000	$16.01	$160,080	17,217
2026-06-30	Watkins Tim	CMO & Head of Development	Sell	10,833	$16.02	$173,590	8,961
2026-06-26	Lyons-Williams Lori	Director	Award	19,000	—	—	19,000
2026-06-26	Ware Olivia C	Director	Award	19,000	—	—	19,000
2026-06-26	Schimmelpennink Evert B.	Director	Award	19,000	—	—	19,000
2026-06-26	Boyce Sarah	Director	Award	19,000	—	—	19,000
2026-06-26	Miralles Gines Diego	Director	Award	19,000	—	—	19,000
2026-06-26	Ignelzi Troy A.	Director	Award	19,000	—	—	19,000
2026-06-26	Brady Todd R.	Director	Award	19,000	—	—	19,000
2026-06-01	Lorrain Daniel S.	Chief Scientific Officer	Sell	4,170	$13.16	$54,862	139,372
2026-05-01	Lorrain Daniel S.	Chief Scientific Officer	Sell	3,870	$13.06	$50,542	143,842
2026-05-01	Lorrain Daniel S.	Chief Scientific Officer	Sell	300	$13.84	$4,152	143,542
2026-04-06	Lorrain Daniel S.	Chief Scientific Officer	Sell	4,170	$13.43	$56,014	147,712
2026-03-02	Watkins Tim	CMO & Head of Development	Convert	3,611	—	—	249,167
2026-03-02	Lorrain Daniel S.	Chief Scientific Officer	Sell	4,170	$15.01	$62,585	151,882
2026-03-02	Watkins Tim	CMO & Head of Development	Convert	3,611	$4.50	$16,250	3,611
2026-03-02	Watkins Tim	CMO & Head of Development	Sell	3,611	$15.02	$54,220	0
2026-02-25	Stengone Carmine N.	Director	Convert	2,700	—	—	120,917
2026-02-25	Stengone Carmine N.	Director	Sell	2,700	$16.02	$43,242	14,954
2026-02-25	Lorrain Daniel S.	Chief Scientific Officer	Convert	3,824	—	—	67,306
2026-02-25	Lorrain Daniel S.	Chief Scientific Officer	Convert	3,824	$1.01	$3,862	159,876
2026-02-25	Stengone Carmine N.	Director	Convert	2,700	$1.26	$3,402	17,654
2026-02-25	Lorrain Daniel S.	Chief Scientific Officer	Sell	3,824	$16.01	$61,228	156,052
2026-02-24	Stengone Carmine N.	Director	Convert	4,400	—	—	123,617
2026-02-24	Lorrain Daniel S.	Chief Scientific Officer	Convert	4,300	—	—	71,130
2026-02-24	Stengone Carmine N.	Director	Sell	4,400	$16.02	$70,486	14,954
2026-02-24	Stengone Carmine N.	Director	Convert	4,400	$1.26	$5,544	19,354
2026-02-24	Lorrain Daniel S.	Chief Scientific Officer	Sell	4,300	$16.03	$68,936	156,052
2026-02-24	Lorrain Daniel S.	Chief Scientific Officer	Convert	4,300	$1.01	$4,343	160,352
2026-02-19	Lorrain Daniel S.	Chief Scientific Officer	Convert	100	—	—	75,430
2026-02-19	Lorrain Daniel S.	Chief Scientific Officer	Sell	100	$16.00	$1,600	156,052
2026-02-19	Lorrain Daniel S.	Chief Scientific Officer	Convert	100	$1.01	$101	156,152
2026-02-11	Stengone Carmine N.	Director	Convert	400	$1.26	$504	15,354
2026-02-11	Lorrain Daniel S.	Chief Scientific Officer	Convert	400	—	—	75,530
2026-02-11	Stengone Carmine N.	Director	Sell	400	$16.00	$6,400	14,954
2026-02-11	Lorrain Daniel S.	Chief Scientific Officer	Convert	400	$1.01	$404	156,452
2026-02-11	Stengone Carmine N.	Director	Convert	400	—	—	128,017

Showing 1–50 of 128 transactions

Key facts CIK 1855175 CUSIP 21217B100 Visit website Investor relations